Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,244 public trials 1,186 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/Bevacizumab Versus the Cisplatin/Docetaxel/Bevacizumab Combination in Locally Advanced or Metastatic NSCLC

NCT00620971

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
  • "Laikon" General Hospital, Medical Oncology Unit, Propedeutic Dep of Internal Medicine Athens, Greece
  • "Metaxa's" Anticancer Hospital of Piraeus,1st Dep of Medical Oncology Athens, Greece
  • 401 Military Hospital, Medical Oncology Unit Athens, Greece
View Trial Details
Completed

EMD 521873 Plus Radiotherapy in Non Small Cell Lung Cancer (NSCLC)

NCT00879866

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Department of Thoracic Oncology, Netherlands Cancer Instiute - Antoni van Leeuwenhoek Hospital Amsterdam, Netherlands
  • Department of Pulmonology, Academic Hosptial Maastricht Masstricht, Netherlands
  • Department of Medical Oncology (452), Radboud UMC Nijmegen Nijmegen, Netherlands
View Trial Details
Completed

Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

NCT00368927

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Lahey Hospital and Medical Center Burlington, Massachusetts, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer

NCT01004250

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Copenhagen, Denmark
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Herlev, Denmark
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Coswig, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Frankfurt, Germany
View all 19 locations
View Trial Details
Completed

National Lung Screening Trial (NLST) Screening

NCT00047385

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Univeristy of California, San Diego La Jolla, California, United States
  • Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
  • University of Colorado Denver Denver, Colorado, United States
View all 33 locations
View Trial Details

Related conditions